Reistone Biopharma Company Limited is a clinical stage biopharmaceutical company focused on developing novel medicines for life threatening autoimmune diseases. Developing therapies for diseases requires new approaches and strong collaboration between scientists, industry, regulators and patient groups. Reistone was forged from the company’s close collaborations with key stakeholders and leading pharmaceutical companies dedicated to transforming new biotechnology insights into breakthrough medicine for significant unmet medical needs in China as well globally.
View Top Employees from Reistone BiopharmaWebsite | http://www.reistonebio.com |
Revenue | $11 million |
Employees | 52 (51 on RocketReach) |
Founded | 2018 |
Technologies |
JavaScript,
HTML,
Nginx
+3 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Reistone Biopharma employee's phone or email?
The Reistone Biopharma annual revenue was $11 million in 2024.
Susan Ciotti is the Vice President and Head of CMC at Reistone Biopharma of Reistone Biopharma.
51 people are employed at Reistone Biopharma.
The NAICS codes for Reistone Biopharma are [32, 325, 32541, 3254].
The SIC codes for Reistone Biopharma are [283, 28].